Skip to content

Viridian Therapeutics, Inc./DE: filings

Every Viridian Therapeutics, Inc./DE annual and quarterly report in the SEC record with the published financial measures it tagged, 49 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 202636940001590750-26-000018
10-Q2026-05-05fiscal Q1 202635730001590750-26-000012
10-K2026-02-26fiscal FY 202539970001590750-26-000007
10-Q2025-11-05fiscal Q3 202536970001590750-25-000020
10-Q2025-08-06fiscal Q2 202535910001590750-25-000012
10-Q2025-05-06fiscal Q1 202535720001590750-25-000008
10-K2025-03-03fiscal FY 202438960001590750-25-000004
10-Q2024-11-12fiscal Q3 2024391110001590750-24-000023
10-Q2024-08-08fiscal Q2 2024391100001590750-24-000019
10-Q2024-05-08fiscal Q1 202439830001590750-24-000012
10-K2024-02-27fiscal FY 2023421090001590750-24-000007
10-Q2023-11-13fiscal Q3 2023391110001590750-23-000013
10-Q2023-08-08fiscal Q2 2023381070001590750-23-000008
10-Q2023-05-10fiscal Q1 202338810001590750-23-000003
10-K2023-03-09fiscal FY 202243880001590750-23-000002
10-Q2022-11-14fiscal Q3 2022401130001590750-22-000012
10-Q2022-08-15fiscal Q2 2022391080001590750-22-000009
10-Q2022-05-13fiscal Q1 202236780001590750-22-000007
10-K2022-03-11fiscal FY 202141850001590750-22-000004
10-Q2021-11-05fiscal Q3 2021401180001590750-21-000075
10-Q2021-08-12fiscal Q2 2021391120001590750-21-000070
10-Q2021-05-07fiscal Q1 202135760001590750-21-000065
10-K2021-03-26fiscal FY 202037770001590750-21-000029
10-Q2020-11-12fiscal Q3 2020381080001590750-20-000106
10-Q2020-08-05fiscal Q2 2020381040001590750-20-000082
10-Q2020-05-08fiscal Q1 202036760001590750-20-000053
10-K2020-03-13fiscal FY 2019401190001590750-20-000021
10-Q2019-11-08fiscal Q3 2019371030001590750-19-000059
10-Q2019-08-08fiscal Q2 201937980001590750-19-000042
10-Q2019-05-09fiscal Q1 201937770001590750-19-000032
10-K2019-03-14fiscal FY 2018391170001590750-19-000013
10-Q2018-11-07fiscal Q3 201837930001590750-18-000027
10-Q2018-08-08fiscal Q2 201837930001590750-18-000018
10-Q2018-05-09fiscal Q1 201834690001590750-18-000012
10-K2018-03-15fiscal FY 2017361110001590750-18-000006
10-Q2017-11-09fiscal Q3 201734850001590750-17-000010
10-Q2017-08-11fiscal Q2 201735870001193125-17-256035
10-Q2017-05-11fiscal Q1 201735710001193125-17-166522
10-K2017-03-24fiscal FY 201634640001171843-17-001747
10-Q2016-10-26fiscal Q3 201632770001171843-16-012638
10-Q2016-08-15fiscal Q2 201634850001171843-16-011777
10-Q2016-05-16fiscal Q1 201634690001171843-16-010081
10-K2016-03-21fiscal FY 201536730001171843-16-008702
10-Q2015-11-13fiscal Q3 201534860001171843-15-006329
10-Q2015-08-14fiscal Q2 201533820001171843-15-004724
10-Q2015-05-15fiscal Q1 201533630001171843-15-002907
10-K2015-03-27fiscal FY 201436740001171843-15-001691
10-Q2014-11-14fiscal Q3 201432820001171843-14-005571
10-Q2014-08-14fiscal Q2 201433830001171843-14-003982

Inspect the source

Entity
Viridian Therapeutics, Inc./DE / CIK 0001590750
Captured
2026-09-20T09:24:00.388Z
SEC response SHA-256
907b594c863d597442ab1ef3a5d74359a9418f23c7e0bb102180e38d47e78bab

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001590750.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))